Effects of Age, Gender, and Body Mass Index on Efficacy and Hypoglycaemia Outcomes Across Treat-To-Target Trials With Insulin Glargine 100 U/mL Added to Oral Antidiabetes Agents in Type 2 Diabetes

Diabetes, Obesity and Metabolism - United Kingdom

doi 10.1111/dom.12966